Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?
01:26pm, Friday, 30'th May 2025
HIMS targets personalized, AI-powered care with bold obesity moves, while AMWL bets on system-wide integration via Converge and top-tier health alliances. Who wins? Let's see.
Hims & Hers Health Stock: After Doubling, It May Be Too Late To Buy
10:22am, Thursday, 29'th May 2025
Hims & Hers Health shows strong growth in subscribers, revenue, and profitability, driven by expanding offerings and strategic partnerships, especially in weight loss and dermatology. HIMS posted stel
Hims & Hers Stock Falls Despite the Latest Wegovy Availability Offer
01:21pm, Wednesday, 28'th May 2025
HIMS launches six-month Wegovy access at $549/month, aiming to expand affordable obesity care with holistic weight loss solutions.
3 Surprising Stocks That Have More Than Doubled in 2025
11:37am, Tuesday, 27'th May 2025
This year has had its ups and downs on Wall Street, but some investments are rolling. There are 14 stocks with market caps north of $1 billion that have more than doubled so far in 2025 -- and some of
Cautious? Risky? Our Volatility Scorecard Can Help
10:13am, Tuesday, 27'th May 2025
Subscribers to Chart of the Week received this commentary on Sunday, May 11.
Hims & Hers Health: New Guidance Creates Huge Risk For Shorts
06:33am, Sunday, 25'th May 2025
Hims & Hers Health continues to fire on all cylinders as a business, growing at extraordinary rates while also improving its margins. Today, I will offer a unique and simplified view of the business b
Avoid These Dividend Disasters Before It's Too Late
08:15am, Friday, 23'rd May 2025
Dividend stocks are facing many big risks. The high interest rates, trade war, and AI revolution could lead to many dividend cuts. I discuss what this all means for dividend investors.
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
03:39pm, Thursday, 22'nd May 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today announced eligible customers can access 6 months of prescription-only Wegovy® at a new, affordable price, making proven obe
Will Hims & Hers Stock Be Okay After UnitedHealth's Sell-Off?
01:57pm, Thursday, 22'nd May 2025
When investors choose to risk their capital in an individual company, they must be aware that the stock market isn't the one-sided machine it used to be a few decades ago. Thanks to the flow of inform
Up 157% in 2025, Is It Too Late to Buy Hims & Hers Stock?
04:22am, Thursday, 22'nd May 2025
Hims & Hers (HIMS -5.42%) has put investors on a roller coaster ride in 2025.
5 Single-Stock ETFs That Doubled in a Month
11:01am, Wednesday, 21'st May 2025
We have highlighted five single-stock ETFs that have doubled over the past month amid a historic Wall Street comeback.
Hims & Hers: After A Bout Of Uncertainty, Upside Remains
07:56am, Wednesday, 21'st May 2025
Hims & Hers continues to deliver strong subscriber and revenue growth, with Q1 2025 revenue up 111% year-over-year and operating leverage improving. The business model's shift to a subscription platfo
Hims & Hers Stock Chart Points to Strong Bullish Continuation
10:16am, Tuesday, 20'th May 2025
Hims and Hers, Inc. NYSE: HIMS shows strongly bullish signs that begin and end with the stock price action. It reflects volatility, but the bias is upward with rising support and the most recent swing
Here's Why You Should Add Hims & Hers Stock to Your Portfolio Now
08:06am, Monday, 19'th May 2025
Hims & Hers leads with AI-powered, personalized health plans (over 70% of new users opt in). Recurring revenues surge as tailored care drives loyalty.
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
11:26am, Friday, 16'th May 2025
HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However, macro challenges may hurt performance.
